Perkins Coie Trust Company’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-200
Closed -$6.8K 330
2025
Q1
$6.8K Hold
200
﹤0.01% 256
2024
Q4
$7.87K Hold
200
﹤0.01% 245
2024
Q3
$9.39K Hold
200
﹤0.01% 248
2024
Q2
$10.8K Hold
200
﹤0.01% 232
2024
Q1
$13.6K Hold
200
﹤0.01% 196
2023
Q4
$12.5K Buy
+200
New +$12.5K ﹤0.01% 202